KalVista Pharmaceuticals, Inc. (KALV)

15.24 +0.30 (+2.01%) USD  |  NASDAQ  |  Jan 14, 16:00
15.25 +0.01 (+0.07%) After-Hours: 20:00
More

KalVista Pharmaceuticals Other Operating Expenses (Quarterly)

Other Operating Expenses (Quarterly) Chart

View Other Operating Expenses (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Operating Expenses (Quarterly) Range, Past 5 Years

View Other Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Operating Expenses (Quarterly) Benchmarks

View Other Operating Expenses (Quarterly) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. --
Silvergate Capital Corp. --
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. --
InfuSystem Holdings, Inc. --